Global burden and trends of respiratory syncytial virus infection across different age groups from 1990 to 2019: A systematic analysis of the Global Burden of Disease 2019 Study
- PMID: 37567553
- DOI: 10.1016/j.ijid.2023.08.008
Global burden and trends of respiratory syncytial virus infection across different age groups from 1990 to 2019: A systematic analysis of the Global Burden of Disease 2019 Study
Abstract
Objective: Understanding the global patterns of respiratory syncytial virus (RSV) is crucial for developing effective prevention and control strategies.
Methods: Data on RSV-related burden were extracted from the Global Burden of Disease 2019. Joinpoint regression models were used to assess the global temporal trends of RSV and further stratified analyses were conducted according to the Socio-demographic Index (SDI), which is a composite measure of income, education, and total fertility. Age-period-cohort model was used to evaluate age, period, and cohort effects.
Results: In 2019, the global age-standardized rate of mortality (ASMR) and disability-adjusted life years (ASR-DALYs) of RSV were 4.79/100,000 (95% uncertainty interval [95% UI]: 1.82/100,000-9.32/100,000) and 218.34/100,000 (95% UI: 92.06/100,000-376.80/100,000), respectively. The burden of RSV was higher in men than women. The highest ASMR (10.26/100,000, 3.80/100,000-20.16/100,000) and ASR-DALYs (478.71/100,000, 202.40/100,000-840.85/100,000) were reported in low-SDI region. Although mortality and DALYs rates in all age groups declined globally, the pace of decline was not uniform across age groups. Mortality rate in the elderly over 70 years surpassed that in children under 5 years in 2019.
Conclusion: This study highlights the need for targeted interventions to reduce the burden of RSV, particularly in low-SDI region, and among the elderly over 70 years.
Keywords: Age-period-cohort model; Epidemiologic characteristics; Respiratory syncytial virus; Trends.
Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors have no competing interests to declare.
Similar articles
-
The global burden of lower respiratory infections attributable to respiratory syncytial virus in 204 countries and territories, 1990-2019: findings from the Global Burden of Disease Study 2019.Intern Emerg Med. 2024 Jan;19(1):59-70. doi: 10.1007/s11739-023-03438-x. Epub 2023 Oct 3. Intern Emerg Med. 2024. PMID: 37789183
-
Global and national burden and trends of mortality and disability-adjusted life years for silicosis, from 1990 to 2019: results from the Global Burden of Disease study 2019.BMC Pulm Med. 2022 Jun 21;22(1):240. doi: 10.1186/s12890-022-02040-9. BMC Pulm Med. 2022. PMID: 35729551 Free PMC article.
-
Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015.Lancet. 2017 May 13;389(10082):1885-1906. doi: 10.1016/S0140-6736(17)30819-X. Epub 2017 Apr 5. Lancet. 2017. PMID: 28390697 Free PMC article.
-
Assessment of the Effects of Active Immunisation against Respiratory Syncytial Virus (RSV) using Decision-Analytic Models: A Systematic Review with a Focus on Vaccination Strategies, Modelling Methods and Input Data.Pharmacoeconomics. 2021 Mar;39(3):287-315. doi: 10.1007/s40273-020-00991-7. Epub 2021 Jan 19. Pharmacoeconomics. 2021. PMID: 33462760 Free PMC article.
-
Disability-adjusted life years for respiratory syncytial virus in children under 2 years.BMC Public Health. 2020 Nov 10;20(1):1679. doi: 10.1186/s12889-020-09796-x. BMC Public Health. 2020. PMID: 33167966 Free PMC article.
Cited by
-
Predictors of prolonged length of hospital stay and in-hospital mortality in patients aged 1-24 months with acute bronchiolitis in Douala, Cameroon.BMC Pediatr. 2024 Feb 29;24(1):150. doi: 10.1186/s12887-024-04653-x. BMC Pediatr. 2024. PMID: 38424505 Free PMC article.
-
Respiratory Syncytial Virus Infections in Recipients of Bone Marrow Transplants: A Systematic Review and Meta-Analysis.Infect Dis Rep. 2024 Mar 29;16(2):317-355. doi: 10.3390/idr16020026. Infect Dis Rep. 2024. PMID: 38667752 Free PMC article. Review.
-
Respiratory Syncytial Virus: A WAidid Consensus Document on New Preventive Options.Vaccines (Basel). 2024 Nov 25;12(12):1317. doi: 10.3390/vaccines12121317. Vaccines (Basel). 2024. PMID: 39771979 Free PMC article. Review.
-
Defining the host dependencies and the transcriptional landscape of RSV infection and bystander activation.bioRxiv [Preprint]. 2025 Mar 26:2025.03.26.645108. doi: 10.1101/2025.03.26.645108. bioRxiv. 2025. Update in: mBio. 2025 Aug 15:e0101025. doi: 10.1128/mbio.01010-25. PMID: 40196489 Free PMC article. Updated. Preprint.
-
Prevalence of Respiratory Syncytial Virus Infection in Hospitalized COPD Patients in Spain Between 2018-2022.Diseases. 2025 Jan 20;13(1):23. doi: 10.3390/diseases13010023. Diseases. 2025. PMID: 39851487 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical